quinazolines has been researched along with azd2932 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashton, S; Hennequin, L; Jung, F; Laine, R; Morgentin, R; Pasquet, G; Plé, PA; Taylor, S | 1 |
1 other study(ies) available for quinazolines and azd2932
Article | Year |
---|---|
Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases.
Topics: Algorithms; Animals; Chemistry, Pharmaceutical; Dogs; Drug Design; Enzyme Inhibitors; Ethers; Female; Humans; Inhibitory Concentration 50; Male; Models, Chemical; Phosphorylation; Quinazolines; Rats; Receptor, Platelet-Derived Growth Factor beta; Vascular Endothelial Growth Factor Receptor-2 | 2012 |